RENAL CELL CANCER
Clinical trials for RENAL CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CANCER trials appear
Sign up with your email to follow new studies for RENAL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to boost cancer immunotherapy
Disease control Recruiting nowThis study is testing a new oral drug called Alintegimod, given alongside standard immunotherapy drugs (ipilimumab and nivolumab), for people with advanced cancers that have spread. The main goals are to find a safe dose and see if the combination helps control the cancer. It is …
Matched conditions: RENAL CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Scientists re-engineer Patients' own cells to hunt down multiple cancers
Disease control Recruiting nowThis study is testing a new type of personalized cell therapy for adults with advanced cancers that have a specific marker called CD70. Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer, and then infuse them back int…
Matched conditions: RENAL CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New study tailors kidney cancer treatment for seniors
Disease control Recruiting nowThis study is looking at how well older adults (70+) with advanced kidney cancer tolerate and respond to a standard two-drug treatment (cabozantinib and nivolumab). Researchers will closely monitor 50 patients' treatment patterns, side effects, and quality of life over time. The …
Matched conditions: RENAL CELL CANCER
Phase: PHASE4 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug tested for Tough-to-Treat kidney cancer
Disease control Recruiting nowThis study is observing how well the drug vorolanib works and how safe it is for patients with advanced kidney cancer that has spread or cannot be removed by surgery. It involves 39 adults who are receiving vorolanib as their second treatment option. Researchers will track how lo…
Matched conditions: RENAL CELL CANCER
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New cancer vaccine trial aims to train immune system to fight tumors
Disease control Recruiting nowThis early-stage study is testing a new cancer vaccine called Modi-1. The goal is to see if it is safe and can help the body's immune system fight advanced forms of breast, head and neck, ovarian, and kidney cancer. Researchers will give the vaccine alone or combined with other a…
Matched conditions: RENAL CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Scancell Ltd • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New imaging tech aims to forecast kidney health after cancer removal
Knowledge-focused Recruiting nowThis study is testing whether advanced ultrasound imaging can predict how well a patient's kidneys will work after surgery to remove kidney cancer. Researchers will use special contrast-enhanced ultrasound scans before and after surgery on about 285 patients to see if the images …
Matched conditions: RENAL CELL CANCER
Sponsor: Jinling Hospital, China • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC